Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: recombinant interleukin-12
Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)